| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/15/2000 | US6025163 DNA coding for a peptide of a papilloma virus main capside protein and use thereof |
| 02/15/2000 | US6025162 Nucleic acid encoding an amino acid sequence of protein; for diagnosis and treatment of allergies |
| 02/15/2000 | US6025161 Introducing vector comprising a mammalian antitrypsin dna sequence into a host cell, culturing cell, then isolating product |
| 02/15/2000 | US6025159 Nucleotide sequence from trigonopsis variabilis; for increased expression of heterologous genes in host systems by replacing promoter of selectable marker, leading to amplification of the plasmid |
| 02/15/2000 | US6025158 Nucleic acids encoding humanized anti-IL-8 monoclonal antibodies |
| 02/15/2000 | US6025156 Amino acid sequence; for discovery of antibiotics, bactericides, bacteristats against staphylococcus infections |
| 02/15/2000 | US6025155 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 02/15/2000 | US6025153 Selectable vectors for human T cells |
| 02/15/2000 | US6025151 Administering compounds to treat a non-swine subject for elevated platelet derived growth factor levels, jun kinase, c-jun or inflammatory cytokines, or activation of nf-kappab or nf-kappab p65 or neutrophil infiltration |
| 02/15/2000 | US6025148 Specifically reactive with the alpha e subunit; for diagnostic information relating to atherogenesis and/or thrombogenesis and pregnancy status or outcome |
| 02/15/2000 | US6025145 Sensitive, reliable immunoassay using eukaryotic cells expressing receptor construct comprising flag polypeptide and tyrosine kinase receptor, exposing to ligand, lysing cells and measuring phosphotyrosine |
| 02/15/2000 | US6025144 Immunoassay test kit for measuring bone resorption |
| 02/15/2000 | US6025143 Purified monoclonal or polyclonal antibody against a peptide having specific amino acid sequence from a gene controlled by andogens and isolated from submaxillary gland of the rat; for diagnosis, detection and therapeutics |
| 02/15/2000 | US6025142 Hydrophobic u-PAR binding site |
| 02/15/2000 | US6025141 Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
| 02/15/2000 | US6025140 Membrane-permeable constructs for transport across a lipid membrane |
| 02/15/2000 | US6025139 Hybridizing sample with oligonucleotides contiguously complementary to wild-type sequence including labeled 3' and 5' probes and at least one intermediate probe, ligating oligonucleotides together, evalutating length and quantity |
| 02/15/2000 | US6025138 Method for detecting the presence of a polynucleotide encoding a hyaluronan receptor expressed in human umbilical vein endothelial cells |
| 02/15/2000 | US6025137 Exposing test sample under high stringency conditions to an isolated nucleic acid that hybridizes to fohy030 messenger rna; rna is from gene which is expressed at a higher level in benign, non-metastatic tumors than in malignant tumors |
| 02/15/2000 | US6025136 Methods and apparatus for DNA sequencing and DNA identification |
| 02/15/2000 | US6025132 Hybridization assay to detect and classify one or more microorganisms in sample using probes and primers from 16s-23s ribosomal rna spacer region of microorganism(s) |
| 02/15/2000 | US6025130 Nucleotide sequence of gene; for screening of homozygotes, diagnosis, and prenatal screening using oligonucleotide primers |
| 02/15/2000 | US6025125 Methods for the detection of HIV-specific immune responses employing non-infectious, non-replicating, IIV retrovirus-like particles containing heterologous antigenic markers |
| 02/15/2000 | US6024966 Gene encoding protein antigens of plasmodium falciparum and uses therefor |
| 02/15/2000 | US6024965 Immunology for treatment of aids and t-cell epitopes |
| 02/15/2000 | US6024962 Mercaptan gene and amine terminus with amine acid nucleic acid sequence |
| 02/15/2000 | US6024961 Recombinant avirulent immunogenic S typhi having rpos positive phenotype |
| 02/15/2000 | US6024958 Polypeptide fragments capable of competition with Streptococcus mutans antigen I/II |
| 02/15/2000 | US6024957 Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same |
| 02/15/2000 | US6024956 Interleukins and antiinflammatrory agents |
| 02/15/2000 | US6024955 Peptide with amino acid sequences |
| 02/15/2000 | US6024953 Prevention of rabies in mammals, administering a hybrid vaccine |
| 02/15/2000 | US6024936 Antibody-based method of localizing activated thrombin receptors |
| 02/15/2000 | US6024878 Chromatographic method for separating a mixture of heteroduplex and homoduplex dna molecules under conditions which selectively denature a mutation site present in the heteroduplex dna molecule |
| 02/15/2000 | US6024638 Fume hood having a driven sash and a travel interference system for the sash |
| 02/15/2000 | CA2223460C Induction of male sterility in plants by expression of high levels of avidin |
| 02/15/2000 | CA2189941C Fluorescence polarization detection of nucleic acids |
| 02/15/2000 | CA2180154C Gene for fatty acid desaturase, vector containing said gene, plant transformed with said gene, and process for creating said plant |
| 02/15/2000 | CA2173106C Bleaching compositions comprising protease enzymes |
| 02/15/2000 | CA2168552C Refolding of polypeptides like recombinant insulin-like growth factor igf-1 |
| 02/15/2000 | CA2093667C Mouse monoclonal antibodies and uses thereof |
| 02/15/2000 | CA2085292C Enzyme of use in chitosan hydrolysis |
| 02/15/2000 | CA2077461C Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway |
| 02/15/2000 | CA2015994C Human lactoferrin cdna sequence |
| 02/15/2000 | CA2006008C Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| 02/15/2000 | CA2005300C Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
| 02/15/2000 | CA2004478C Monoclonal antibodies to feline-t-lymphotropic lentivirus |
| 02/15/2000 | CA1340900C Method for indentifying and using biosynthetic or regulatory genes for enhanced production of secondary metabolites |
| 02/12/2000 | CA2248989A1 Novel compounds |
| 02/10/2000 | WO2000007038A2 Protein fragment complementation assays |
| 02/10/2000 | WO2000007018A2 Three-hybrid screening method for ligand-protein interactions |
| 02/10/2000 | WO2000007014A2 Leptin-mediated gene-induction |
| 02/10/2000 | WO2000006780A1 Methods and reagents for preserving rna in cell and tissue samples |
| 02/10/2000 | WO2000006779A1 Reversible inhibiting probes |
| 02/10/2000 | WO2000006778A1 Wavelength-shifting probes and primers |
| 02/10/2000 | WO2000006777A2 Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals |
| 02/10/2000 | WO2000006776A1 Genotyping human udp-glucuronosyltransferase 2b4 (ugt2b4), 2b7 (ugt2b7) and 2b15 (ugt2b15) genes |
| 02/10/2000 | WO2000006775A1 Exon deletion antisense drug design and therapy |
| 02/10/2000 | WO2000006773A1 Method of and composite for fluorescent in situ hybridization |
| 02/10/2000 | WO2000006772A1 Mutations in and genomic structure of herg - a long qt syndrome gene |
| 02/10/2000 | WO2000006771A2 Nucleic acid labeling compounds |
| 02/10/2000 | WO2000006770A1 Arrayed biomolecules and their use in sequencing |
| 02/10/2000 | WO2000006769A2 Human ccr-2 gene polymorphisms |
| 02/10/2000 | WO2000006768A1 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases |
| 02/10/2000 | WO2000006767A1 Genetic polymorphisms in the human neurokinin 2 receptor gene and their use in diagnosis and treatment of diseases |
| 02/10/2000 | WO2000006765A1 Differential staining of bacteria using fluorescence |
| 02/10/2000 | WO2000006764A1 Gastrointestinal bacterial antibody factories |
| 02/10/2000 | WO2000006763A1 Fusion products containing insoluble proteinaceous tag |
| 02/10/2000 | WO2000006760A1 Use of constitutive transport elements for host range control |
| 02/10/2000 | WO2000006759A2 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 02/10/2000 | WO2000006758A1 Self-deleting vectors for cancer therapy |
| 02/10/2000 | WO2000006757A1 Improved plant transformation process by scaffold attachment regions (sar) |
| 02/10/2000 | WO2000006756A1 Sulfur metabolism enzymes |
| 02/10/2000 | WO2000006755A2 Modification of starch biosynthetic enzyme gene expression to produce starches in grain crops |
| 02/10/2000 | WO2000006754A2 Engineering nematode resistance in solanacae |
| 02/10/2000 | WO2000006753A1 Engineering nematode resistance in solanacae |
| 02/10/2000 | WO2000006752A1 Bending and/or leaning-induced plant promoter |
| 02/10/2000 | WO2000006751A2 Repressor proteins producing cell lines for the propagation of vectors |
| 02/10/2000 | WO2000006750A2 Method for autoactivation of procaspase 8 |
| 02/10/2000 | WO2000006749A2 Sulfur metabolism enzymes |
| 02/10/2000 | WO2000006748A2 Crystallizable farnesyl protein transferase compositions, crystals thereby obtained and methods for use |
| 02/10/2000 | WO2000006747A2 Enzymes for biopolymer production |
| 02/10/2000 | WO2000006746A1 Methods and means for inducing tolerance to stress |
| 02/10/2000 | WO2000006745A1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 02/10/2000 | WO2000006744A1 Granulocytic ehrlichia genes and uses thereof |
| 02/10/2000 | WO2000006743A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006742A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006741A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006740A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006739A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006738A2 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 02/10/2000 | WO2000006737A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 02/10/2000 | WO2000006736A2 Nucleic acids and proteins from group b streptococcus |
| 02/10/2000 | WO2000006735A1 Interferon alpha hybrids |
| 02/10/2000 | WO2000006734A1 Chondrogenic and osteogenic inducing molecule |
| 02/10/2000 | WO2000006733A2 T cell receptor proteins, nucleic acid molecules, and uses thereof |
| 02/10/2000 | WO2000006732A2 Polynucleotide encoding an autoantigen associated with endometriosis |
| 02/10/2000 | WO2000006731A2 PERSEPHIN ARF, A PROTEIN ENCODED BY UNSPLICED PERSEPHIN mRNA |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006729A1 Kdel receptor inhibitors |